Skip to main content
Top
Published in: European Journal of Pediatrics 3/2003

01-03-2003 | Original Paper

Pulmonary re-occurrence of post-transplant lymphoproliferative disease with hypogammaglobulinaemia

Authors: Matthias T. F. Wolf, Eva Mildenberger, Thomas Lennert, Ioannis Anagnostopoulos, Christina Zinn, Karl Paul, Rolf Keitzer, Hans Versmold

Published in: European Journal of Pediatrics | Issue 3/2003

Login to get access

Abstract

We report the case of a 12-year-old boy, who developed Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disease (PTLD) 7 years after renal transplantation. He responded well to the reduced immunosuppressive therapy and treatment with ganciclovir. Two years later he developed severe pneumonia and hypogammaglobulinaemia related to EBV infection exacerbation. An X-ray film revealed persistent pneumonia in the right lung. Lung biopsy showed a large, diffuse EBV-associated B-cell lymphoma. This constellation suggested re-occurrence of the primary PTLD. Conclusion: We present a case of recurring Epstein-Barr virus-associated post-transplant lymphoproliferative disease with a remarkably late onset in addition to hypogammaglobulinaemia.
Literature
1.
go back to reference Aloy Duch A, Hernandez Hernandez JA, Muniz Diaz E, Hernandez Regi M, Llibre Codina JM, Gonzalez-Moreno Portugal M (1992) Severe leukopenia and thrombocytopenia and hypogammaglobulinemia in a patient with transient acquired with infectious mononucleosis. Med Clin (Barc) 22: 260–262 Aloy Duch A, Hernandez Hernandez JA, Muniz Diaz E, Hernandez Regi M, Llibre Codina JM, Gonzalez-Moreno Portugal M (1992) Severe leukopenia and thrombocytopenia and hypogammaglobulinemia in a patient with transient acquired with infectious mononucleosis. Med Clin (Barc) 22: 260–262
2.
go back to reference Chand DH, Southerland SM, Cunningham III RJ (2001) Tacrolimus: the good, the bad, and the ugly. Pediatr Transplant 5: 32–36CrossRefPubMed Chand DH, Southerland SM, Cunningham III RJ (2001) Tacrolimus: the good, the bad, and the ugly. Pediatr Transplant 5: 32–36CrossRefPubMed
3.
go back to reference Cockfield SM (2001) Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 3: 70–78CrossRefPubMed Cockfield SM (2001) Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 3: 70–78CrossRefPubMed
4.
go back to reference Collins MH, Montone KT, Leahey AM, Hodinka RL, Salhany KE, Kramer DL, Deng C, Tomaszewski JE (2001) Post-transplant lymphoproliferative disease in children. Pediatr Transplant 5: 250–257CrossRefPubMed Collins MH, Montone KT, Leahey AM, Hodinka RL, Salhany KE, Kramer DL, Deng C, Tomaszewski JE (2001) Post-transplant lymphoproliferative disease in children. Pediatr Transplant 5: 250–257CrossRefPubMed
5.
go back to reference Ellis D, Jaffe R, Green M, Janosky JJ, Lombardozzi-Lane S, Shapiro R, Scantlebury V, Vivas C, Jordan ML (1999) Epstein-Barr virus related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. Transplantation 68: 997–1003CrossRefPubMed Ellis D, Jaffe R, Green M, Janosky JJ, Lombardozzi-Lane S, Shapiro R, Scantlebury V, Vivas C, Jordan ML (1999) Epstein-Barr virus related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. Transplantation 68: 997–1003CrossRefPubMed
6.
go back to reference Green M, Reyes J, Webber S, Rowe D (2001) The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation. Transpl Infect Dis 3: 97–103CrossRefPubMed Green M, Reyes J, Webber S, Rowe D (2001) The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation. Transpl Infect Dis 3: 97–103CrossRefPubMed
7.
go back to reference Herbert D, Sullivan EK (1998) Malignancy and posttransplant lymphoproliferative disorder (PTLD) in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transpl 2[Suppl 1]: 57 Herbert D, Sullivan EK (1998) Malignancy and posttransplant lymphoproliferative disorder (PTLD) in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transpl 2[Suppl 1]: 57
8.
go back to reference Ho M, Jaffe R, Miller G, Breinig MK, Dummer JS, Makowka L, Atchison RW, Karrer F, Nalesnik MA, Starzl TE (1988) The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestation in children. Transplantation 45: 719–727CrossRefPubMedPubMedCentral Ho M, Jaffe R, Miller G, Breinig MK, Dummer JS, Makowka L, Atchison RW, Karrer F, Nalesnik MA, Starzl TE (1988) The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestation in children. Transplantation 45: 719–727CrossRefPubMedPubMedCentral
9.
go back to reference Hsieh WS, Lemas MV, Ambinder RF (1999) The biology of Epstein-Barr virus in post-transplant lymphoprolifrative disease. Transpl Infect Dis 1: 204–212CrossRefPubMed Hsieh WS, Lemas MV, Ambinder RF (1999) The biology of Epstein-Barr virus in post-transplant lymphoprolifrative disease. Transpl Infect Dis 1: 204–212CrossRefPubMed
10.
go back to reference Kawa K (2000) Epstein-Barr virus associated diseases in humans. Int J Hematol 71: 108–117PubMed Kawa K (2000) Epstein-Barr virus associated diseases in humans. Int J Hematol 71: 108–117PubMed
11.
go back to reference Larratt LM, Hamilton M, Coupland R, Preiksaitis JK (2001) Recurrent Epstein-Barr virus associated disease in a cardiac transplant patient: evolution from plasmacytic hyperplasia to diffuse large cell lymphoma. Transpl Infect Dis 3: 119–123CrossRefPubMed Larratt LM, Hamilton M, Coupland R, Preiksaitis JK (2001) Recurrent Epstein-Barr virus associated disease in a cardiac transplant patient: evolution from plasmacytic hyperplasia to diffuse large cell lymphoma. Transpl Infect Dis 3: 119–123CrossRefPubMed
12.
go back to reference Linde A, Soderstrom R, Smith CI, Sallberg M, Dahl H, Grubb R, Bjorkander J, Hammastrom L (1992) Herpesvirus serology, aberrant specific immunoglobulin G2 and G3 subclass patterns and Gm allotypes in individuals with low levels of IgG3. Clin Exp Immunol 90: 199–203PubMedPubMedCentral Linde A, Soderstrom R, Smith CI, Sallberg M, Dahl H, Grubb R, Bjorkander J, Hammastrom L (1992) Herpesvirus serology, aberrant specific immunoglobulin G2 and G3 subclass patterns and Gm allotypes in individuals with low levels of IgG3. Clin Exp Immunol 90: 199–203PubMedPubMedCentral
13.
go back to reference Montone KT, Hodinka RL, Salhany KE, Lavi E, Rostami A, Tomaszewski JE (1996) Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease. Mod Pathol 9: 621–630PubMed Montone KT, Hodinka RL, Salhany KE, Lavi E, Rostami A, Tomaszewski JE (1996) Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease. Mod Pathol 9: 621–630PubMed
14.
go back to reference Nalesnik MA (2001) The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach. Transpl Infect Dis 3: 88–96CrossRefPubMed Nalesnik MA (2001) The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach. Transpl Infect Dis 3: 88–96CrossRefPubMed
15.
go back to reference Saulsbury FT (1989) Selective IgA deficiency temporally associated with Epstein-Barr virus infection. J Pediatr 115: 268–270CrossRefPubMed Saulsbury FT (1989) Selective IgA deficiency temporally associated with Epstein-Barr virus infection. J Pediatr 115: 268–270CrossRefPubMed
16.
17.
go back to reference Tanner JE, Alfieri C (2001) The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis. Transpl Infect Dis 3: 60–69CrossRefPubMed Tanner JE, Alfieri C (2001) The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis. Transpl Infect Dis 3: 60–69CrossRefPubMed
18.
go back to reference Yamani MH, Avery RK, Mawhorter SD, Young JB, Ratliff NB, Hobbs RE, McCarthy PM, Smedira NG, Goormastic M, Pelegrin RN, Starling RC (2001) Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection. J Heart Lung Transplant 20: 425–430CrossRefPubMed Yamani MH, Avery RK, Mawhorter SD, Young JB, Ratliff NB, Hobbs RE, McCarthy PM, Smedira NG, Goormastic M, Pelegrin RN, Starling RC (2001) Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection. J Heart Lung Transplant 20: 425–430CrossRefPubMed
19.
go back to reference Yu DT, Clements PJ, Paulus HE, Peter JB, Levy J, Barnett EV (1974) Human lymphocyte subpopulations. Effects of corticosteroids. J Clin Invest 53: 565–571CrossRefPubMedPubMedCentral Yu DT, Clements PJ, Paulus HE, Peter JB, Levy J, Barnett EV (1974) Human lymphocyte subpopulations. Effects of corticosteroids. J Clin Invest 53: 565–571CrossRefPubMedPubMedCentral
20.
go back to reference Wu TT, Swerdlow SH, Locker J (1996) Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. Hum Pathol 27: 157–164CrossRefPubMed Wu TT, Swerdlow SH, Locker J (1996) Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. Hum Pathol 27: 157–164CrossRefPubMed
Metadata
Title
Pulmonary re-occurrence of post-transplant lymphoproliferative disease with hypogammaglobulinaemia
Authors
Matthias T. F. Wolf
Eva Mildenberger
Thomas Lennert
Ioannis Anagnostopoulos
Christina Zinn
Karl Paul
Rolf Keitzer
Hans Versmold
Publication date
01-03-2003
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Pediatrics / Issue 3/2003
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-002-1120-8

Other articles of this Issue 3/2003

European Journal of Pediatrics 3/2003 Go to the issue

News for the Practitioner

Prenatal exposure to PCB and dioxin: